You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
NEW YORK (GenomeWeb News) – The Forsyth Institute plans to use a $4.1 million grant from the Massachusetts Life Sciences Center (MLSC) to create a new center that will develop saliva-based molecular diagnostic tests for assessing disease risk.
This article has been updated to clarify that the Forsyth Institute was the recipient of the Gates Foundation grant.
Scientists at Forsyth will focus on discovering biomarkers in saliva that may indicate metabolic disease and the development of diabetes.
A team of researchers based in Germany and China used 16S rRNA sequencing to begin cataloguing the bacterial genera in saliva samples from 120 people around the world in search of informative bugs.
Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.
A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.
In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.
According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.